Loading…
Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma
Abstract Purpose The purpose of the study was to review a single-institution experience with endoscopic resection of sinonasal undifferentiated carcinoma (SNUC). Materials and Methods Thirteen patients underwent treatment of SNUC between January 2002 and July 2009. Retrospective data were collected...
Saved in:
Published in: | American journal of otolaryngology 2011-11, Vol.32 (6), p.464-469 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c474t-e96a53b303cec7ba246ea0a145cbc9c9e6774d1a7e22b51667573d1f3ab471dc3 |
---|---|
cites | cdi_FETCH-LOGICAL-c474t-e96a53b303cec7ba246ea0a145cbc9c9e6774d1a7e22b51667573d1f3ab471dc3 |
container_end_page | 469 |
container_issue | 6 |
container_start_page | 464 |
container_title | American journal of otolaryngology |
container_volume | 32 |
creator | Revenaugh, Peter C., MD Seth, Rahul, MD Pavlovich, Justin B., MD Knott, P. Daniel, MD Batra, Pete S., MD |
description | Abstract Purpose The purpose of the study was to review a single-institution experience with endoscopic resection of sinonasal undifferentiated carcinoma (SNUC). Materials and Methods Thirteen patients underwent treatment of SNUC between January 2002 and July 2009. Retrospective data were collected including demographics, tumor characteristics, surgical strategy, adjuvant therapies, local and regional recurrence, distant metastasis, overall survival, and disease-free survival. Results The mean age was 51.8 years. The most common tumor stage at presentation was T4 (92%). Seven patients (53%) were treated with minimally invasive endoscopic resection (MIER) with negative intraoperative margins. Endoscopic anterior skull base resection was performed in 5 patients, and endoscopic-assisted bifrontal craniotomy was performed in 1 patient to clear the superior tumor margin. Six patients received pre- or postoperative chemoradiation. One patient underwent palliative chemoradiation, and one patient underwent open craniofacial resection. In the MIER group, simultaneous local and regional recurrence was observed in 1 patient (14%) after 30 months. Distant metastases were observed in 2 other patients (28%) without local or regional recurrence. All 3 patients with recurrences died of their disease. The remaining 4 patients were clinically, endoscopically, and radiographically free of disease, resulting in overall and disease-free survival rates of 57% with mean follow-up of 32.3 months. Conclusions These preliminary data suggest a potential role for MIER in the comprehensive management algorithm of SNUC in appropriately selected patients. Patient outcomes including local and regional recurrence, distant metastases, and overall and disease-free survival were comparable to a treatment strategy using traditional craniofacial resection. Level of evidence 2b. |
doi_str_mv | 10.1016/j.amjoto.2010.09.006 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_901308424</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S019607091000181X</els_id><sourcerecordid>2730091231</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-e96a53b303cec7ba246ea0a145cbc9c9e6774d1a7e22b51667573d1f3ab471dc3</originalsourceid><addsrcrecordid>eNqFkt-L1DAQgIMo3t7pfyBSELmnrjNNmmxfBDn8BSf3oMK9hTSdQmqbrEm7sP-9Kbt6cC8-BZJvJjPfDGOvELYIKN8NWzMNYQ7bCvIVNFsA-YRtsOZVucPd_VO2AWxkCQqaC3aZ0gAAXPD6ObuoEAQC4IbdfXPeTWYcj4XzB5PcgQryXUg27J0tIiWyswu-CH2RnA_eJDMWi-9c31MkPzszU1dYE21-ncwL9qw3Y6KX5_OK_fz08cfNl_L27vPXmw-3pRVKzCU10tS85cAtWdWaSkgyYFDUtrWNbUgqJTo0iqqqrVFKVSveYc9NKxR2ll-x61PefQy_F0qznlyyNI7GU1iSbgA57EQlMvnmETmEJfpcnEbgqEACrJQ4UTaGlCL1eh-zl3jMkF5960GffOvVt4ZGZ9857PU5-dJO1P0L-is4A2_PgEnWjH003rr0wGUbUvCVe3_iKEs7OIo6WUfeUudinoDugvtfJY8T2DGPNv_5i46UHnrWqdKgv6-7sa5GrhJwh_f8D6WgtUI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1031706004</pqid></control><display><type>article</type><title>Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma</title><source>ScienceDirect Journals</source><creator>Revenaugh, Peter C., MD ; Seth, Rahul, MD ; Pavlovich, Justin B., MD ; Knott, P. Daniel, MD ; Batra, Pete S., MD</creator><creatorcontrib>Revenaugh, Peter C., MD ; Seth, Rahul, MD ; Pavlovich, Justin B., MD ; Knott, P. Daniel, MD ; Batra, Pete S., MD</creatorcontrib><description>Abstract Purpose The purpose of the study was to review a single-institution experience with endoscopic resection of sinonasal undifferentiated carcinoma (SNUC). Materials and Methods Thirteen patients underwent treatment of SNUC between January 2002 and July 2009. Retrospective data were collected including demographics, tumor characteristics, surgical strategy, adjuvant therapies, local and regional recurrence, distant metastasis, overall survival, and disease-free survival. Results The mean age was 51.8 years. The most common tumor stage at presentation was T4 (92%). Seven patients (53%) were treated with minimally invasive endoscopic resection (MIER) with negative intraoperative margins. Endoscopic anterior skull base resection was performed in 5 patients, and endoscopic-assisted bifrontal craniotomy was performed in 1 patient to clear the superior tumor margin. Six patients received pre- or postoperative chemoradiation. One patient underwent palliative chemoradiation, and one patient underwent open craniofacial resection. In the MIER group, simultaneous local and regional recurrence was observed in 1 patient (14%) after 30 months. Distant metastases were observed in 2 other patients (28%) without local or regional recurrence. All 3 patients with recurrences died of their disease. The remaining 4 patients were clinically, endoscopically, and radiographically free of disease, resulting in overall and disease-free survival rates of 57% with mean follow-up of 32.3 months. Conclusions These preliminary data suggest a potential role for MIER in the comprehensive management algorithm of SNUC in appropriately selected patients. Patient outcomes including local and regional recurrence, distant metastases, and overall and disease-free survival were comparable to a treatment strategy using traditional craniofacial resection. Level of evidence 2b.</description><identifier>ISSN: 0196-0709</identifier><identifier>EISSN: 1532-818X</identifier><identifier>DOI: 10.1016/j.amjoto.2010.09.006</identifier><identifier>PMID: 21041001</identifier><identifier>CODEN: AJOTDP</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Aged ; Biological and medical sciences ; Biopsy, Needle ; Carcinoma - mortality ; Carcinoma - pathology ; Carcinoma - surgery ; Carcinoma - therapy ; Chemoradiotherapy - methods ; Chemotherapy ; Cohort Studies ; Confidence Intervals ; Disease-Free Survival ; Endoscopy - methods ; Female ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Male ; Maxillary Sinus Neoplasms - mortality ; Maxillary Sinus Neoplasms - pathology ; Maxillary Sinus Neoplasms - surgery ; Maxillary Sinus Neoplasms - therapy ; Medical sciences ; Medical treatment ; Middle Aged ; Minimally Invasive Surgical Procedures - methods ; Mortality ; Neoplasm Invasiveness - pathology ; Neoplasm Recurrence, Local - mortality ; Neoplasm Recurrence, Local - pathology ; Neoplasm Staging ; Otolaryngology ; Otorhinolaryngology. Stomatology ; Paranasal Sinus Neoplasms - mortality ; Paranasal Sinus Neoplasms - pathology ; Paranasal Sinus Neoplasms - surgery ; Paranasal Sinus Neoplasms - therapy ; Prognosis ; Radiation therapy ; Retrospective Studies ; Sinuses ; Surgery ; Survival Analysis ; Young Adult</subject><ispartof>American journal of otolaryngology, 2011-11, Vol.32 (6), p.464-469</ispartof><rights>Elsevier Inc.</rights><rights>2011 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-e96a53b303cec7ba246ea0a145cbc9c9e6774d1a7e22b51667573d1f3ab471dc3</citedby><cites>FETCH-LOGICAL-c474t-e96a53b303cec7ba246ea0a145cbc9c9e6774d1a7e22b51667573d1f3ab471dc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24746431$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21041001$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Revenaugh, Peter C., MD</creatorcontrib><creatorcontrib>Seth, Rahul, MD</creatorcontrib><creatorcontrib>Pavlovich, Justin B., MD</creatorcontrib><creatorcontrib>Knott, P. Daniel, MD</creatorcontrib><creatorcontrib>Batra, Pete S., MD</creatorcontrib><title>Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma</title><title>American journal of otolaryngology</title><addtitle>Am J Otolaryngol</addtitle><description>Abstract Purpose The purpose of the study was to review a single-institution experience with endoscopic resection of sinonasal undifferentiated carcinoma (SNUC). Materials and Methods Thirteen patients underwent treatment of SNUC between January 2002 and July 2009. Retrospective data were collected including demographics, tumor characteristics, surgical strategy, adjuvant therapies, local and regional recurrence, distant metastasis, overall survival, and disease-free survival. Results The mean age was 51.8 years. The most common tumor stage at presentation was T4 (92%). Seven patients (53%) were treated with minimally invasive endoscopic resection (MIER) with negative intraoperative margins. Endoscopic anterior skull base resection was performed in 5 patients, and endoscopic-assisted bifrontal craniotomy was performed in 1 patient to clear the superior tumor margin. Six patients received pre- or postoperative chemoradiation. One patient underwent palliative chemoradiation, and one patient underwent open craniofacial resection. In the MIER group, simultaneous local and regional recurrence was observed in 1 patient (14%) after 30 months. Distant metastases were observed in 2 other patients (28%) without local or regional recurrence. All 3 patients with recurrences died of their disease. The remaining 4 patients were clinically, endoscopically, and radiographically free of disease, resulting in overall and disease-free survival rates of 57% with mean follow-up of 32.3 months. Conclusions These preliminary data suggest a potential role for MIER in the comprehensive management algorithm of SNUC in appropriately selected patients. Patient outcomes including local and regional recurrence, distant metastases, and overall and disease-free survival were comparable to a treatment strategy using traditional craniofacial resection. Level of evidence 2b.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Biopsy, Needle</subject><subject>Carcinoma - mortality</subject><subject>Carcinoma - pathology</subject><subject>Carcinoma - surgery</subject><subject>Carcinoma - therapy</subject><subject>Chemoradiotherapy - methods</subject><subject>Chemotherapy</subject><subject>Cohort Studies</subject><subject>Confidence Intervals</subject><subject>Disease-Free Survival</subject><subject>Endoscopy - methods</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Maxillary Sinus Neoplasms - mortality</subject><subject>Maxillary Sinus Neoplasms - pathology</subject><subject>Maxillary Sinus Neoplasms - surgery</subject><subject>Maxillary Sinus Neoplasms - therapy</subject><subject>Medical sciences</subject><subject>Medical treatment</subject><subject>Middle Aged</subject><subject>Minimally Invasive Surgical Procedures - methods</subject><subject>Mortality</subject><subject>Neoplasm Invasiveness - pathology</subject><subject>Neoplasm Recurrence, Local - mortality</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Staging</subject><subject>Otolaryngology</subject><subject>Otorhinolaryngology. Stomatology</subject><subject>Paranasal Sinus Neoplasms - mortality</subject><subject>Paranasal Sinus Neoplasms - pathology</subject><subject>Paranasal Sinus Neoplasms - surgery</subject><subject>Paranasal Sinus Neoplasms - therapy</subject><subject>Prognosis</subject><subject>Radiation therapy</subject><subject>Retrospective Studies</subject><subject>Sinuses</subject><subject>Surgery</subject><subject>Survival Analysis</subject><subject>Young Adult</subject><issn>0196-0709</issn><issn>1532-818X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqFkt-L1DAQgIMo3t7pfyBSELmnrjNNmmxfBDn8BSf3oMK9hTSdQmqbrEm7sP-9Kbt6cC8-BZJvJjPfDGOvELYIKN8NWzMNYQ7bCvIVNFsA-YRtsOZVucPd_VO2AWxkCQqaC3aZ0gAAXPD6ObuoEAQC4IbdfXPeTWYcj4XzB5PcgQryXUg27J0tIiWyswu-CH2RnA_eJDMWi-9c31MkPzszU1dYE21-ncwL9qw3Y6KX5_OK_fz08cfNl_L27vPXmw-3pRVKzCU10tS85cAtWdWaSkgyYFDUtrWNbUgqJTo0iqqqrVFKVSveYc9NKxR2ll-x61PefQy_F0qznlyyNI7GU1iSbgA57EQlMvnmETmEJfpcnEbgqEACrJQ4UTaGlCL1eh-zl3jMkF5960GffOvVt4ZGZ9857PU5-dJO1P0L-is4A2_PgEnWjH003rr0wGUbUvCVe3_iKEs7OIo6WUfeUudinoDugvtfJY8T2DGPNv_5i46UHnrWqdKgv6-7sa5GrhJwh_f8D6WgtUI</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Revenaugh, Peter C., MD</creator><creator>Seth, Rahul, MD</creator><creator>Pavlovich, Justin B., MD</creator><creator>Knott, P. Daniel, MD</creator><creator>Batra, Pete S., MD</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20111101</creationdate><title>Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma</title><author>Revenaugh, Peter C., MD ; Seth, Rahul, MD ; Pavlovich, Justin B., MD ; Knott, P. Daniel, MD ; Batra, Pete S., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-e96a53b303cec7ba246ea0a145cbc9c9e6774d1a7e22b51667573d1f3ab471dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Biopsy, Needle</topic><topic>Carcinoma - mortality</topic><topic>Carcinoma - pathology</topic><topic>Carcinoma - surgery</topic><topic>Carcinoma - therapy</topic><topic>Chemoradiotherapy - methods</topic><topic>Chemotherapy</topic><topic>Cohort Studies</topic><topic>Confidence Intervals</topic><topic>Disease-Free Survival</topic><topic>Endoscopy - methods</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Maxillary Sinus Neoplasms - mortality</topic><topic>Maxillary Sinus Neoplasms - pathology</topic><topic>Maxillary Sinus Neoplasms - surgery</topic><topic>Maxillary Sinus Neoplasms - therapy</topic><topic>Medical sciences</topic><topic>Medical treatment</topic><topic>Middle Aged</topic><topic>Minimally Invasive Surgical Procedures - methods</topic><topic>Mortality</topic><topic>Neoplasm Invasiveness - pathology</topic><topic>Neoplasm Recurrence, Local - mortality</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Staging</topic><topic>Otolaryngology</topic><topic>Otorhinolaryngology. Stomatology</topic><topic>Paranasal Sinus Neoplasms - mortality</topic><topic>Paranasal Sinus Neoplasms - pathology</topic><topic>Paranasal Sinus Neoplasms - surgery</topic><topic>Paranasal Sinus Neoplasms - therapy</topic><topic>Prognosis</topic><topic>Radiation therapy</topic><topic>Retrospective Studies</topic><topic>Sinuses</topic><topic>Surgery</topic><topic>Survival Analysis</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Revenaugh, Peter C., MD</creatorcontrib><creatorcontrib>Seth, Rahul, MD</creatorcontrib><creatorcontrib>Pavlovich, Justin B., MD</creatorcontrib><creatorcontrib>Knott, P. Daniel, MD</creatorcontrib><creatorcontrib>Batra, Pete S., MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of otolaryngology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Revenaugh, Peter C., MD</au><au>Seth, Rahul, MD</au><au>Pavlovich, Justin B., MD</au><au>Knott, P. Daniel, MD</au><au>Batra, Pete S., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma</atitle><jtitle>American journal of otolaryngology</jtitle><addtitle>Am J Otolaryngol</addtitle><date>2011-11-01</date><risdate>2011</risdate><volume>32</volume><issue>6</issue><spage>464</spage><epage>469</epage><pages>464-469</pages><issn>0196-0709</issn><eissn>1532-818X</eissn><coden>AJOTDP</coden><abstract>Abstract Purpose The purpose of the study was to review a single-institution experience with endoscopic resection of sinonasal undifferentiated carcinoma (SNUC). Materials and Methods Thirteen patients underwent treatment of SNUC between January 2002 and July 2009. Retrospective data were collected including demographics, tumor characteristics, surgical strategy, adjuvant therapies, local and regional recurrence, distant metastasis, overall survival, and disease-free survival. Results The mean age was 51.8 years. The most common tumor stage at presentation was T4 (92%). Seven patients (53%) were treated with minimally invasive endoscopic resection (MIER) with negative intraoperative margins. Endoscopic anterior skull base resection was performed in 5 patients, and endoscopic-assisted bifrontal craniotomy was performed in 1 patient to clear the superior tumor margin. Six patients received pre- or postoperative chemoradiation. One patient underwent palliative chemoradiation, and one patient underwent open craniofacial resection. In the MIER group, simultaneous local and regional recurrence was observed in 1 patient (14%) after 30 months. Distant metastases were observed in 2 other patients (28%) without local or regional recurrence. All 3 patients with recurrences died of their disease. The remaining 4 patients were clinically, endoscopically, and radiographically free of disease, resulting in overall and disease-free survival rates of 57% with mean follow-up of 32.3 months. Conclusions These preliminary data suggest a potential role for MIER in the comprehensive management algorithm of SNUC in appropriately selected patients. Patient outcomes including local and regional recurrence, distant metastases, and overall and disease-free survival were comparable to a treatment strategy using traditional craniofacial resection. Level of evidence 2b.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>21041001</pmid><doi>10.1016/j.amjoto.2010.09.006</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0196-0709 |
ispartof | American journal of otolaryngology, 2011-11, Vol.32 (6), p.464-469 |
issn | 0196-0709 1532-818X |
language | eng |
recordid | cdi_proquest_miscellaneous_901308424 |
source | ScienceDirect Journals |
subjects | Adolescent Adult Aged Biological and medical sciences Biopsy, Needle Carcinoma - mortality Carcinoma - pathology Carcinoma - surgery Carcinoma - therapy Chemoradiotherapy - methods Chemotherapy Cohort Studies Confidence Intervals Disease-Free Survival Endoscopy - methods Female Humans Immunohistochemistry Kaplan-Meier Estimate Male Maxillary Sinus Neoplasms - mortality Maxillary Sinus Neoplasms - pathology Maxillary Sinus Neoplasms - surgery Maxillary Sinus Neoplasms - therapy Medical sciences Medical treatment Middle Aged Minimally Invasive Surgical Procedures - methods Mortality Neoplasm Invasiveness - pathology Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - pathology Neoplasm Staging Otolaryngology Otorhinolaryngology. Stomatology Paranasal Sinus Neoplasms - mortality Paranasal Sinus Neoplasms - pathology Paranasal Sinus Neoplasms - surgery Paranasal Sinus Neoplasms - therapy Prognosis Radiation therapy Retrospective Studies Sinuses Surgery Survival Analysis Young Adult |
title | Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T17%3A28%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Minimally%20invasive%20endoscopic%20resection%20of%20sinonasal%20undifferentiated%20carcinoma&rft.jtitle=American%20journal%20of%20otolaryngology&rft.au=Revenaugh,%20Peter%20C.,%20MD&rft.date=2011-11-01&rft.volume=32&rft.issue=6&rft.spage=464&rft.epage=469&rft.pages=464-469&rft.issn=0196-0709&rft.eissn=1532-818X&rft.coden=AJOTDP&rft_id=info:doi/10.1016/j.amjoto.2010.09.006&rft_dat=%3Cproquest_cross%3E2730091231%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-e96a53b303cec7ba246ea0a145cbc9c9e6774d1a7e22b51667573d1f3ab471dc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1031706004&rft_id=info:pmid/21041001&rfr_iscdi=true |